Education
About Us
Working with TipRanks
Follow Us
Larimar Therapeutics, Inc. (LRMR)
NASDAQ:LRMR
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -350.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -172.50M | $ -90.89M | $ -41.76M | $ -36.53M | $ -50.47M |
| EBITDA | $ -172.50M | $ -90.57M | $ -41.45M | $ -36.21M | $ -50.14M |
| Net Income | $ -165.67M | $ -80.60M | $ -36.95M | $ -35.35M | $ -50.64M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 136.85M | $ 183.45M | $ 86.79M | $ 118.43M | $ 70.10M |
| Total Assets | $ 145.84M | $ 200.22M | $ 95.94M | $ 126.41M | $ 78.67M |
| Total Debt | $ 4.07M | $ 5.12M | $ 5.55M | $ 5.41M | $ 6.00M |
| Net Debt | $ -81.34M | $ -28.10M | $ -21.20M | $ -21.42M | $ -64.09M |
| Total Liabilities | $ 67.76M | $ 28.41M | $ 14.21M | $ 15.50M | $ 14.25M |
| Stockholders' Equity | $ 78.08M | $ 171.81M | $ 81.72M | $ 110.90M | $ 64.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -113.29M | $ -71.28M | $ -33.62M | $ -27.67M | $ -42.44M |
| Operating Cash Flow | $ -113.20M | $ -70.76M | $ -33.46M | $ -27.57M | $ -42.10M |
| Investing Cash Flow | $ 100.31M | $ -85.39M | $ 33.35M | $ -90.96M | $ 24.17M |
| Financing Cash Flow | $ 65.09M | $ 161.88M | $ 30.00K | $ 75.26M | $ 19.89M |